ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

EU Pharma Laboratory Design Consultancy Expands To US, APAC, LATAM Markets

A design consultancy specializing in cannabis laboratory design is now offering its services to startups outside the EU.

-- Hempire Labs S.L. (Hempire Labs) in Andalucia has announced that it has moved to offer its cannabis laboratory design services to startups outside the European Union in a global expansion effort. The company's leadership said the group aims to respond to the demand of business owners to achieve the stamp of approval of a number of accrediting bodies to gain a competitive advantage.

More information is available at https://hempirelabs.eu/

A representative for Hempire Labs said that since the legalization of cannabis in a number of markets and the subsequent boom of the industry, investors seeking to put up their own labs have sought guidance in design to obtain certifications like good manufacturing practices (GMP) as proof of good quality control. "The reality is that cannabis-based product manufacturing is no longer part of some fringe market; it is a billion-dollar industry now with regulations that must be met by new entrants."

Fortune Business Insights' latest forecast in February 2025 states that the global cannabis market is expected to register a compound annual growth rate of 34.03% between 2023 and 2030.

For investors looking to enter the fast-growing market, Hempire Labs can assist in the design of laboratories that are compliant with a number of critical standards, primarily GMP, which applies to manufacturing processes and facilities; good agricultural and collection practices (GACP) for ensuring quality control in cultivation, harvesting, and collection of cannabis plant material; and good distribution practices (GDP), which refer to standards for moving cannabis products through the supply chain.

Leading the team is Mardi Joubanian, a long-time veteran in the medical cannabis segment. Mr. Joubanian has helped establish a number of medical cannabis startups and is now bringing his experience to Hempire Labs S.L. to help clients identify the latest technology to ensure maximum purity and potency of their respective products.

Co-founder Paulina Molyneux-Webb is in charge of project management. She brings to the organization her vast experience in leading complex projects in the pharmaceutical industry. As an educator, she is keen on continuous improvement and the latest developments in herbal remedies.

Hempire Labs S.L. charges a nominal fee of $125 for an online consultation prior to a full-on engagement.

Interested parties who want to know more can schedule a call through https://hempirelabs.eu/

Contact Info:
Name: Paulina Molyneux-Webb
Email: Send Email
Organization: Hempire Labs S.L.
Address: POLIGONO NUEVA CAMPANA, 93 NAVE, Marbella, AndalucĂ­a 29660, Spain
Website: https://hempirelabs.eu

Source: NewsNetwork

Release ID: 89155075

In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.